Evidence map›Paper›PMID 40667464›Full record

SynthesisFrontiers in neurology2025

Bibliometric and visualized analysis of current advances and future directions in epilepsy: from molecular basis to therapy.

Chengqiang Du, Xinlei Xu, Yehui Lv, Fang Tong, Ruofan Lin, Zhifang Yang

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chengqiang DuSchool of Basic Medical Sciences, Institute of Wound Prevention and Treatment, Shanghai University of Medicine and Health Sciences, Shanghai, China.
Xinlei XuShanghai First Maternity and Infant Hospital, Shanghai, China.
Yehui LvSchool of Basic Medical Sciences, Institute of Wound Prevention and Treatment, Shanghai University of Medicine and Health Sciences, Shanghai, China.
Fang TongSchool of Basic Medical Sciences, Institute of Wound Prevention and Treatment, Shanghai University of Medicine and Health Sciences, Shanghai, China.
Ruofan LinSchool of Basic Medical Sciences, Institute of Wound Prevention and Treatment, Shanghai University of Medicine and Health Sciences, Shanghai, China.
Zhifang YangSchool of Basic Medical Sciences, Institute of Wound Prevention and Treatment, Shanghai University of Medicine and Health Sciences, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Through a visual analysis of the literature on epilepsy research in the Web of Science Core Collection, this study aims to explore the molecular basis, providing a reference for scholars and professionals in related fields. Methods: The search formula is generated using the Mesh keyword list in PubMed. Subsequently, English-language literature is retrieved from the Web of Science Core Collection, with the search period set from January 1, 2015, to December 31, 2024. The study calculates the annual number of publications and citations and analyzes the trends. CiteSpace 6.2. R4 software is used to perform a visual analysis of the retrieved documents. Results: The search retrieved 1,485 articles related to molecular basis of epilepsy research, with an average annual growth rate of 14.41%. Based on the publication trend line for this period, it is predicted that approximately 208 articles will be published in this field in 2025. Conclusion: This study examines the dynamic evolution of epilepsy from molecular mechanisms to clinical treatment. Ion channel abnormalities (e.g., KCNQ2 and SCN1A mutations) and neuroinflammatory pathways have become central to basic research, guiding targeted drug design. However, gaps remain between basic research and clinical application, as discoveries like circRNA regulation and glial-neuron interactions have not yet led to effective therapies, and emerging technologies such as optogenetics and nano-drug delivery systems still require clinical validation.

Indexed as

bibliometricsepilepsyion channelneurotransmittertargeted therapyvisual analysis

Identifiers

PMID40667464
PMCPMC12260245

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.